ATE73781T1 - Organische verbindungen und ihre pharmazeutische verwendung. - Google Patents

Organische verbindungen und ihre pharmazeutische verwendung.

Info

Publication number
ATE73781T1
ATE73781T1 AT86309402T AT86309402T ATE73781T1 AT E73781 T1 ATE73781 T1 AT E73781T1 AT 86309402 T AT86309402 T AT 86309402T AT 86309402 T AT86309402 T AT 86309402T AT E73781 T1 ATE73781 T1 AT E73781T1
Authority
AT
Austria
Prior art keywords
sub
sup
alkyl
hydrogen
optionally
Prior art date
Application number
AT86309402T
Other languages
English (en)
Inventor
Stephen Richard Baker
Alec Todd
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Application granted granted Critical
Publication of ATE73781T1 publication Critical patent/ATE73781T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT86309402T 1985-12-07 1986-12-03 Organische verbindungen und ihre pharmazeutische verwendung. ATE73781T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858530222A GB8530222D0 (en) 1985-12-07 1985-12-07 Organic compounds
EP86309402A EP0235452B1 (de) 1985-12-07 1986-12-03 Organische Verbindungen und ihre pharmazeutische Verwendung

Publications (1)

Publication Number Publication Date
ATE73781T1 true ATE73781T1 (de) 1992-04-15

Family

ID=10589419

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86309402T ATE73781T1 (de) 1985-12-07 1986-12-03 Organische verbindungen und ihre pharmazeutische verwendung.

Country Status (8)

Country Link
US (1) US4845110A (de)
EP (1) EP0235452B1 (de)
JP (1) JPS62187445A (de)
AT (1) ATE73781T1 (de)
DE (1) DE3684457D1 (de)
ES (1) ES2033242T3 (de)
GB (2) GB8530222D0 (de)
GR (1) GR3004104T3 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5143931A (en) * 1982-06-24 1992-09-01 Smithkline Beecham Corporation Leukotriene antagonists containing tetrazolyl groups
US4939279A (en) * 1985-04-19 1990-07-03 Smithkline Beecham Corporation Leukotriene antagonists
DE3604050A1 (de) * 1986-02-08 1987-08-13 Boehringer Mannheim Gmbh Thioether, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
PT87616B (pt) * 1987-06-24 1992-09-30 Smithkline Beecham Corp Processo de preparacao de antagonistas do leucotrieno e de composicoes farmaceuticas
GB8725260D0 (en) * 1987-10-28 1987-12-02 Lilly Industries Ltd Organic compounds
GB8807016D0 (en) * 1988-03-24 1988-04-27 Lilly Industries Ltd Organic compounds & their pharmaceutical use
US5221760A (en) * 1988-05-13 1993-06-22 Bayer Aktiengesellschaft Alkenoic acid derivatives
GB2218416A (en) * 1988-05-13 1989-11-15 Bayer Ag Leukotriene disease antagonists
US4954513A (en) * 1988-12-23 1990-09-04 Smithkline Beecham Corporation Leukotriene antagonists
GB9100493D0 (en) * 1991-01-10 1991-02-20 Bayer Ag Substituted alkenoic acid and its derivatives
WO2025215083A1 (en) 2024-04-10 2025-10-16 Dipharma Francis S.R.L. Method for preparing a drug used for paroxysmal supraventricular tachycardia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8320943D0 (en) * 1983-08-03 1983-09-07 Lilly Industries Ltd Organic compounds
GB8432144D0 (en) * 1984-12-20 1985-01-30 Lilly Industries Ltd Organic compounds
GB8502258D0 (en) * 1985-01-30 1985-02-27 Lilly Industries Ltd Organic compounds

Also Published As

Publication number Publication date
GB2184121A (en) 1987-06-17
JPS62187445A (ja) 1987-08-15
GR3004104T3 (de) 1993-03-31
GB8628960D0 (en) 1987-01-07
GB8530222D0 (en) 1986-01-15
US4845110A (en) 1989-07-04
EP0235452A3 (en) 1988-10-26
ES2033242T3 (es) 1993-03-16
EP0235452B1 (de) 1992-03-18
DE3684457D1 (de) 1992-04-23
EP0235452A2 (de) 1987-09-09
GB2184121B (en) 1990-04-11

Similar Documents

Publication Publication Date Title
MY102762A (en) Novel organic compounds and their pharmaceutical use.
ES8603408A1 (es) Un procedimiento para la preparacion de un compuesto de 2-oxindol-1-carboxamida
NO892381L (no) 1-indolylalkyl-4-(substituert-pyridinyl)piperaziner.
ATE76864T1 (de) Aromatische polycyclische derivate, verfahren zu ihrer herstellung und ihre verwendung in pharmazeutischen und kosmetischen zubereitungen.
ES8604964A1 (es) Un procedimiento para la preparacion de derivados de imida- zodiacepina
DE3684457D1 (de) Organische verbindungen und ihre pharmazeutische verwendung.
ATE44729T1 (de) Entzuendungshemmende guanidine, deren herstellung und diese enthaltende zusammensetzungen.
ES8306753A1 (es) "procedimiento para la preparacion de nuevos derivados de azepina".
ES8604991A1 (es) Un metodo para preparar peptidos farmaceuticamente activos
ES437261A1 (es) Procedimiento para la preparacion de nuevas 6-aril-4h-s- triazolo-(3, 4c)-tieno-(2, 3e)-1, 4-diazepinas sustituidas.
BG101484A (bg) Използване на естери на 3-арилакрилова киселина като средства за защита от светлина и като стабилизатори на нежив органичен материал
ES2066701B1 (es) Perfeccionamientos en el objeto de la patente 9102594 por procedimiento de obtencion de compuestos derivados de piridina.
ES8801211A1 (es) Un procedimiento para preparar derivados de quinolona
ES2000456A6 (es) Procedimiento para preparar deirvados de acido eicosatriinoico-5,8,11 y utilizacion de estos en composiciones farmaceuticas y cosmeticas.
ATE69050T1 (de) Organische verbindungen und ihre pharmazeutische verwendung.
ES8205770A1 (es) Procedimiento para la preparacion de derivados de 2,3-indo- lediona
DK274086A (da) Substituerede phenyleddikesyreamidforbindelser og farmaceutisk acceptable salte heraf samt farmaceutisk komposition med antiinflammatorisk og analgetisk virkning indeholdende disse
DE3688960D1 (de) Synthese von Beta-Lactamverbindungen.
GB8725260D0 (en) Organic compounds
JPS6413083A (en) Streptonigrin derivative and medicinal composition
ES2042499T3 (es) Procedimiento para preparar un derivado de acido 2-piridilacetico.
ATE38984T1 (de) Isocyanato-azetidin-dionen.
DK428686A (da) Naphthalenderivater
ES8202554A1 (es) Procedimiento para la preparacion de 2-fenilamino-imidazoli-nas-(2)sustituidas
SE7809127L (sv) Allenaminer

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee